TE_15155
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE order | LINE |
| Gene | EYA4, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 402.00 |
| Counts of samples | TCGA_tumor:1069; TCGA_normal:2; GTEx:0 |
| TSS | chr6(+):133147901 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_15155.41 | EYA4 | Chimeric | Non-coding | Non-coding | chr6(+):133147902,133148165,133241628,133241749,133245179,133245229,133246864,133246884 |
| teRNA_15155.42 | EYA4 | Chimeric | Non-coding | Non-coding | chr6(+):133147902,133148165,133241628,133241749,133245098,133245229,133246864,133246884 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
